Journals / The Anatolian Journal of Cardiology / 2018 / Cilt: 19 - Sayı: 6

Current state of risk stratification for sudden cardiac death in adults with congenital heart disease

Pages
401–403
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The discriminative ability for SCD of the guidelines was poor, with an area under the receiver operating characteristic curve of 0.61-0.63.Risk stratification for SCD in ACHD patients, therefore, remains to be a work-in-progress.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Sudden cardiac death (SCD), mainly caused by ventricular arrhythmias, is one of the leading causes of mortality in adult congenital heart disease(ACHD) patients.
📊
Key Findings & Data:Among SCD cases, 35%-41% of patients were recommended ICD, whereas 16%-17% of controls were recommendedICD.
💡
Conclusion & Impact:The discriminative ability for SCD of the guidelines was poor, with an area under the receiver operating characteristic curve of 0.61-0.63.Risk stratification for SCD in ACHD patients, therefore, remains to be a work-in-progress.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Sudden cardiac death (SCD), mainly caused by ventricular arrhythmias, is one of the leading causes of mortality in adult congenital heart disease(ACHD) patients. An implantable cardioverter defibrillator (ICD) may prevent SCD, but risk stratification remains challenging. In this review,we will address the current guideline recommendations for ICD implantation in ACHD patients, as well as review a recent study in which thediscriminative ability for SCD of these guidelines is evaluated. In this study, the guideline recommendations were applied to patients who diedof SCD and living controls. Among SCD cases, 35%-41% of patients were recommended ICD, whereas 16%-17% of controls were recommendedICD. The discriminative ability for SCD of the guidelines was poor, with an area under the receiver operating characteristic curve of 0.61-0.63.Risk stratification for SCD in ACHD patients, therefore, remains to be a work-in-progress.

🔖

Cite This Article

VEHMEİJER, J. T., MULDER, B. J. M., GROOT, J. R. D. (2018). Current state of risk stratification for sudden cardiac death in adults with congenital heart disease. The Anatolian Journal of Cardiology, Cilt: 19 - Sayı: 6, 401–403. https://ajindex.com/articles/365789

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Koyak Z, Harris L, de Groot JR, Silversides CK, Oechslin EN, Bouma BJ, et al. Sudden cardiac death in adult congenital heart disease. Circulation 2012
  2. [CrossRef] 2. Gallego P, Gonzalez AE, Sanchez-Recalde A, Peinado R, Polo L, Gomez-Rubin C, et al. Incidence and predictors of sudden cardiac arrest in adults with congenital heart defects repaired before adult life. Am J Cardiol 2012
  3. [CrossRef] 3. Vehmeijer JT, Brouwer TF, Limpens J, Knops RE, Bouma BJ, Mulder BJ, et al. Implantable cardioverter-defibrillators in adults with con-genital heart disease: a systematic review and meta-analysis. Eur Heart J 2016
  4. [CrossRef] 4. Priori SG, Blomstrom-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. 2015 ESC Guidelines for the management of pa-tients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Car-diac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 2015
  5. [CrossRef] 5. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for con-gestive heart failure. N Engl J Med 2005
  6. [CrossRef] 6. Khairy P, Harris L, Landzberg MJ, Viswanathan S, Barlow A, Gat-zoulis MA, et al. Implantable cardioverter-defibrillators in tetralogy of Fallot. Circulation 2008
  7. [CrossRef] 7. Khairy P, Van Hare GF, Balaji S, Berul CI, Cecchin F, Cohen MI, et al. PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the Amer-ican College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Cana-dian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Heart Rhythm 2014
  8. e102-65. [CrossRef] 8. Vehmeijer JT, Koyak Z, Budts W, Harris L, Silversides CK, Oechslin EN, et al. Prevention of Sudden Cardiac Death in Adults With Con-genital Heart Disease: Do the Guidelines Fall Short? Circ Arrhythm Electrophysiol 2017
  9. pii: e005093. [CrossRef] 9. Swets JA. Measuring the